The living room European Cannabis London will be held in four weeks, at a time when there is a lot of interest in the emergence of a potential European cannabis market.
Changing attitudes towards cannabis, economic forces and heightened sensitivity to social justice issues are just some of the factors that are rocking the legalization of adult use in Europe.
Sales of legal cannabis for adult use in Europe could reach 1.6 billion euros by 2027 if Germany legalizes the sale of cannabis, and taking into account cannabis regulations in the Czech Republic, Switzerland and the The Netherlands.
Over the same period, the medical cannabis patient population is expected to grow in countries such as France, the UK and Poland, bringing the total number of medical cannabis patients in Europe to around 1.43 million. , an increase of 234% over the forecast period (2023-2027).
It is in this context that Cannabis Europa, Europe’s leading cannabis policy event, returns to London on May 2 and 3, 2023, at the Barbican Center in London. The annual event will bring together over 1,500 policymakers, industry operators, investors and advocates from over 37 nations to discuss the state of the industry and the global opportunities emerging in the region.
Dorien Rookmaker, MEP from the Netherlands, who will participate in the EU Better Believe It roundtable, stressed that there are big questions ahead for the sector. “The increasing legalization of the medical and recreational use of cannabis has created enormous opportunities around the world. International standards and better legislation are of great importance. What are the next steps ? »
Cannabis Europa will analyze the key market growth drivers, as well as the upcoming opportunities and challenges. Chief among them is the timing of legalization in Europe and how the regulations will impact the speed and growth of the market.
“Even though it seems slow, Europe is about to create a new way of dealing with cannabis – fair, accessible, but still highly regulated,” said Dirk Heitepriem, vice president of the German Association of Cannabis. cannabis industry, who will speak during the “State of the Art Session: Germany”.
The European cannabis market has always been stricter than the US market in terms of product diversity and access, even for medical use, and this is unlikely to change, even if the laws surrounding the substance evolve for security reasons. Despite this, combined sales of CBD, medical cannabis and adult cannabis will reach nearly €6.5 billion by 2027, according to the latest report from Prohibition Partners, the group behind Cannabis Europa.
“Prohibition seems to have completely failed the cannabis industry and the market has not only stabilized but is also growing. This is why we must find better control instruments. A strictly regulated market can regulate what is produced, where, by whom and how much is sold. A total ban cannot do that,” says Czech national drug coordinator Jindrich Voboril. “A regulated market has a greater potential for preventing damage”.
The two-day program will feature a prestigious group of advocates, innovators, policymakers and investors who will engage in meaningful conversations about how to move this market forward.
You can enjoy a discount on your entries with the following codes:
- 15% VIP Ticket Discount: NEWSWEED15
- 10% Standard Ticket Discount: 10NEWSWEED
To find out more about Cannabis Europa and to register for the event, you can visit their website at the following address: www.cannabis-europa.com
Why go to Cannabis Europa?
Cannabis Europa brings together on stage some of the most prominent voices in the global industry, the leaders and pioneers shaping the future of cannabis in Europe.
Since 2018, Cannabis Europa has been Europe’s premier cannabis event, attracting over 1,500 attendees from over 37 countries for two days of industry information and networking. At this event, attendees have a unique chance to connect with influential leaders of successful cannabis companies, investors actively working in the market, and important policy makers.
This powerful combination of industrial expertise, financial acumen and political influence is precisely what the European cannabis industry needs to move forward.